AxoGen raised a round of funding on September 30, 2011. Investors include
LecTec.
AxoGen aims to provide surgeons a biological solution to repair and regenerate peripheral nerves, bringing relief and restoring functionality to patients who suffer peripheral nerve injuries.…
